This infographic showcases Europe's top 5 ophthalmology players by revenue in the reporting period 2018–2022: Veonet Group, Sanoptis, Artemis Augenkliniken, Clinica Baviera, and Optegra.
Last week Romesh Angunawela told us how doctors across a range of outpatient specialities are becoming increasingly interested in setting up their own businesses. This week we hear a bit more from him about how this trend applies to ophthalmology in particular, and why he co-founded OCL Vision, a three-clinic ophtha group in the UK.
Doctors are becoming increasingly interested in setting up clinics and running them as proper businesses. We spoke to Romesh Angunawela, who has recently completed an MBA especially for physicians in the US, and is the co-founder of OCL Vision, a three-clinic ophtha group in the UK. He shared his view on this trend and the factors driving it.
Consolidation has been the primary way that PE-backed private health care groups have grown in Europe. A lot of the low hanging fruit has now been picked. But canny investors are adopting new models to open up new consolidation opportunities.
Multinational investment bank and financial services company Jefferies published its 2023 Healthcare Temperature Check report this week, to coincide with its healthcare conference which ran between Tuesday and Thursday this week.
HBI attended the Global Health Exhibition in Riyadh, Saudi Arabia, and saw first-hand how the country is changing ahead of its 2030 transformation plan. Here are our three key takeaways from the event.
A German outpatient operator tells HBI how providers are attracting and keeping patients within their businesses throughout the patient pathway, with as many as 50% of complex ophthalmology referrals coming from internal sources. HBI hears it pays to do basic (less profitable) work and even consider retail early in the patient journey so when they really do need help, they already have a provider of choice.
The UK independent sector is gearing up for an explosion in backlog-busting public outsourcing. The for-profit hospital, ophthalmology and imaging markets in particular look set for a significant boost according to wide-reaching government plans announced today (January 4).
Ophthalmology continues to be a big area of interest for investors, with considerable scope for consolidation. An expert panel including the CEO of Europe's largest chain (Veonet) and the CEO of Latin America's largest player (Opty) discussed opportunities in the sector at HBI 2023.
The UK NHS was once globally revered, but cracks are showing as it marks seventy-five years and a question mark hangs over its future. HBI asks half a dozen experts what role for-profits have in its future - and whether it will it last another 75 years.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
